新西兰药剂机构在更年期妇女对替代药物的反弹中审查Estradot 资金筹供问题。 New Zealand's Pharmac agency reviews Estradot patch funding amid menopausal women's backlash over alternatives.

新西兰药剂机构正在考虑是否继续资助Estradot为更年期妇女建造的Estradot补丁,因为公众反对一种效果较差的替代方法。 New Zealand's Pharmac agency is considering whether to continue funding the Estradot patch for menopausal women after public backlash over a less effective alternative. 现在 Pharmac 正在与供应商和消费者团体进行咨询. With over 1300 signatures on a petition, Pharmac is now consulting suppliers and consumer groups. 他们将在2025年1月底举行公开协商,并提供最新情况,确保在这一进程期间仍可使用现有的补丁。 They will hold a public consultation and provide an update in late January 2025, ensuring current patches remain available during this process.